Market Research Logo

North America Crispr Market Forecast 2019-2027

North America Crispr Market Forecast 2019-2027

KEY FINDINGS

Over the forecast period of 2019-2027, the North America CRISPR market is projected to witness a CAGR of 31.97% accounting for the highest revenue share, as compared to other regional markets.

MARKET INSIGHTS

Pharmaceutical industries are the key end-users of the CRISPRs in this region. Also, the growing market for stem cell therapy is considerably fueling the demand for the CRISPR market. Increasing grant for orphan drug status for stem cell therapeutics by the FDA, an extensive government funding and the presence of major leading market companies in the region are some of the important factors propelling the growth of this market. The US is considered to be a lucrative market in this region, driven by increased healthcare spending. The Canadian Budget 2016, too, played a significant role in the development of CRISPR market in the region by funding various research activities of genomics, drug discovery and stem cell research.

COMPETITIVE INSIGHTS

Noted players in this market include Crispr Therapeutics Ag, Novartis International Ag, Integrated DNA Technologies (IDT), Editas Medicine, Genscript, Cellectis Bioresearch Sas, Precision Biosciences, Transposagen Biopharmaceuticals Inc, Sigma-Aldrich (Merck), Intellia Therapeutics Inc, and Origene Technologies Inc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Plasmids Hold The Largest Market Share In Terms Of Products
3.2.2. Industrial Biotech Is The Fastest Growing End User
3.2.3. Genome Editing/ Genetic Engineering Is Majorly Used Application
4. Market Determinants
4.1. Market Drivers
4.1.1. Increasing Demand For Drug Discovery
4.1.2. Late Pregnancies Leading To Birth Disorders
4.1.3. Risk Of Congenital Anamolities
4.1.4. Aging Geriatric Population
4.1.5. Changing Lifestyles
4.1.6. Prevalence Of Genetic Disorders
4.1.7. Increasing Genetic Diseases
4.1.8. Growing Awareness Regarding Gene Therapeutics
4.2. Market Restraints
4.2.1. Possible Misuse Of Crispr Gene Editing Tool
4.2.2. Lack Of Awareness
4.2.3. Lack Of Healthcare Budgets In Developing Countries
4.2.4. Stringent Regulations
4.3. Market Opportunities
4.3.1. Genome Surgery To Rewrite Genetic Disorders
4.3.2. Growing Usages Of Potential Applications Of Crispr Technology
4.4. Market Challenges
4.4.1. Protection Of Patent
4.4.2. Alternate Technologies
4.4.3. Ethical Issues
5. Market By Product
5.1. Design Tools
5.2. Plasmids
5.3. Vectors
5.4. Library
5.5. Control Kits
5.6. Proteins
5.7. Grna
5.8. Other Products
6. Market By End User
6.1. Biological Research
6.2. Agricultural Biotech
6.3. Industrial Biotech
6.4. Therapeutics And Drug Discovery
7. Market By Application
7.1. Genome Editing/ Genetic Engineering
7.2. Grna Database/Gene Library
7.3. Crispr Plasmid
7.4. Human Stem Cells
7.5. Cell Line Engineering
8. Key Analytics
8.1. Porter’s 5 Force Model
8.1.1. Threats Of New Entrants
8.1.2. Threat Of Substitutes
8.1.3. Bargaining Power Of Buyer
8.1.4. Bargaining Power Of Supplier
8.1.5. Intensity Of Competitive Rivalry
8.2. Market Etymology
8.3. Supply Chain Analysis
8.4. Regulatory Framework
8.5. Regulatory Bodies
8.6. Value Chain Analysis
8.7. Key Buying Criteria
8.8. Patent Analysis
8.9. Strategic Recommendation And Conclusion
8.10. Pipeline Analysis
9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada
10. Competitive Analysis
10.1. Market Share Analysis
10.2. Company Profile
10.2.1. Addgene
10.2.2. Applied Stemcell, Inc.
10.2.3. Caribou Biosciences Inc.
10.2.4. Cellectis Bioresearch Sas
10.2.5. Crispr Therapeutics Ag
10.2.6. Diacarta, Inc.
10.2.7. Edigene, Inc.
10.2.8. Editas Medicine
10.2.9. Genecopoeia, Inc.
10.2.10. Genedata Ag
10.2.11. Genscript
10.2.12. Horizon Discovery Plc.
10.2.13. Integrated Dna Technologies
10.2.14. Intellia Therapeutics Inc
10.2.15. Lonza Group Ag
10.2.16. New England Biolabs Inc
10.2.17. Novartis International Ag
10.2.18. Origene Technologies Inc
10.2.19. Precision Biosciences
10.2.20. Sangamo Therapeutics
10.2.21. Sigma-aldrich (Merck)
10.2.22. Thermo Fisher Scientific
10.2.23. Transposagen Biopharmaceuticals Inc.
List Of Tables
Table 1 North America Crispr Market 2019-2027 ($ Millions)
Table 2 Major Concerns Related With Genetic Engineering
Table 3 North America Crispr Market By Product 2019-2027 ($ Millions)
Table 4 Tools Name And Their Providers
Table 5 North America Design Tools Market 2019-2027 ($ Millions)
Table 6 North America Plasmids Market 2019-2027 ($ Millions)
Table 7 North America Vectors Market 2019-2027 ($ Millions)
Table 8 North America Library Market 2019-2027 ($ Millions)
Table 9 North America Control Kits Market 2019-2027 ($ Millions)
Table 10 North America Proteins Market 2019-2027 ($ Millions)
Table 11 North America Grna Market 2019-2027 ($ Millions)
Table 12 North America Other Products Market 2019-2027 ($ Millions)
Table 13 North America Crispr Market By End User 2019-2027 ($ Millions)
Table 14 North America Biological Research Market 2019-2027 ($ Million)
Table 15 North America Agricultural Biotech Market 2019-2027 ($ Million)
Table 16 North America Industrial Biotech Market 2019-2027 ($ Million)
Table 17 North America Therapeutics And Drug Discovery Market 2019-2027 ($ Million)
Table 18 North America Crispr Marke By Application 2019-2027 ($ Millions)
Table 19 North America Genome Editing/ Genetic Engineering Market 2019-2027 ($ Millions)
Table 20 Barriers To Entry In The Agricultural Seed Market
Table 21 Traits And Technology History Of Plant Biotech
Table 22 Agriculture Biotech Traits Industry
Table 23 Company Related To Agriculture Biotechnology Involved In Genome Editing Tool Crispr
Table 24 Agricultural Biotechnology Company Licensing Crispr Products
Table 25 Key Competitors In The Agricultural Biologicals Industry
Table 26 North America Grna Database/Gene Library Market 2019-2027 ($ Millions)
Table 27 North America Crispr Plasmid Market 2019-2027 ($ Millions)
Table 28 North America Human Stem Cells Market 2019-2027 ($ Millions)
Table 29 North America Cell Line Engineering Market 2019-2027 ($ Millions)
Table 30 North America Crisper Market 2019-2027 ($ Million)
Table 31 North America Crisper Market By Country 2019-2027 ($ Million)
Table 32 Funds Allocated For Research Activities In Budget 2016
Table 33 Gm Crops Grown In Canada
List Of Figures
s
Figure 1 Fatalities Increasing Due To Lifestyle Oriented Diseases (In Thousand)
Figure 2 North America Crispr Market By Design Tools 2019-2027 ($ Millions)
Figure 3 North America Crispr Market By Plasmids 2019-2027 ($ Millions)
Figure 4 North America Crispr Market By Vectors 2019-2027 ($ Millions)
Figure 5 North America Crispr Market By Library 2019-2027 ($ Millions)
Figure 6 North America Crispr Market By Control Kits 2019-2027 ($ Millions)
Figure 7 North America Crispr Market By Proteins 2019-2027 ($ Millions)
Figure 8 North America Crispr Market By Grna 2019-2027 ($ Millions)
Figure 9 North America Crispr Market By Other Products 2019-2027 ($ Millions)
Figure 10 North America Crispr Market By Biological Research 2019-2027 ($ Million)
Figure 11 North America Crispr Market By Agricultural Biotech 2019-2027 ($ Million)
Figure 12 North America Crispr Market By Industrial Biotech2019-2027 ($ Million)
Figure 13 North America Crispr Market By Therapeutics And Drug Discovery 2019-2027 ($ Million)
Figure 14 North America Crispr Market By Genome Editing/ Genetic Engineering 2019-2027 ($ Millions)
Figure 15 North America Crispr Market By Grna Database/Gene Library 2019-2027 ($ Millions)
Figure 16 North America Crispr Market By Crispr Plasmid 2019-2027 ($ Millions)
Figure 17 North America Crispr Market By Human Stem Cells 2019-2027 ($ Millions)
Figure 18 North America Crispr Market By Cell Line Engineering 2019-2027 ($ Millions)
Figure 19 Value Chain Analysis
Figure 20 North America Crisper Market 2019-2027 ($ Million)
Figure 21 Adoption Of Gmo Crops In The U.S. In 2017 (%)
Figure 22 The United States Crispr Market 2019-2027 ($ Million)
Figure 23 Reasons For Adopting Genetically Engineered Crop (Bt Cotton)
Figure 24 Gm Crops Grown In Canada
Figure 25 Canada Crisper Market 2019-2027 ($ Million)
Figure 26 Crispr Market Companies Share 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report